We provides assistance with design, approval, and execution of pilot studies and preclinical trials, to assist and accelerate the process of moving scientific breakthroughs from the research bench to the clinic. Our goal is to support and encourage translational efforts using refined animal models of disease to test:
- Chemotherapeutic response and drug resistance
- Biosensors for tumor detection and monitoring
- Diagnostic assays
- Cancer vaccines
- Drug delivery systems and tumor-targeted modalities
Access is available to all members of the MIT community, to the extent permitted by available capacity. Priority access is given to KI members and NCI-funded research projects in recognition of funding support. In special circumstances, access may be available to non-MIT users.